The exact mechanism responsible for infusion-related reactions (IRRs) after monoclonal antibody (mAb) therapy is unclear. It is also unknown before treatment which patient will develop IRRs. The ...
Pemivibart has been available in the US since March 2024 under an emergency use authorisation for adults and adolescents aged ...
On the same day North Carolina hospitals reported a record number of COVID-19 patients in intensive care units across the state, Gov. Roy Cooper signaled he will take action expanding access to a ...
Investing.com -- The U.S. Food and Drug Administration (FDA) has approved Roche Holding AG’s (SIX:RO) Gazyva/Gazyvaro (obinutuzumab) for treating adult patients with active lupus nephritis who are ...
A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...
A potential first-in-class therapy for migraine prevention has shown promise in a phase 2a proof-of-concept study, with a single infusion reducing migraine frequency over 4 weeks. The drug Lu AG09222 ...
SAN DIEGO – Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH) – a rare, aggressive hyperinflammatory condition – who were treated with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback